Testing effectiveness (Phase 2)Ended earlyNCT02013791
What this trial is testing
Phase 2 Study of a New Ophthalmic Formulation of Cyclosporine (Restasis® X) in Patients With Dry Eye Disease
Who this might be right for
Dry Eye Syndromes
Allergan 55
Showing 20 of 0 results